Cosmo Pharmaceuticals NV (CHIX:COPNZ) Pre-Tax Income : CHF18.8 Mil (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Cosmo Pharmaceuticals NV Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cosmo Pharmaceuticals NV's pretax income for the six months ended in Jun. 2023 was CHF3.6 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was CHF18.8 Mil. Cosmo Pharmaceuticals NV's pretax margin was 8.41%.

During the past 13 years, Cosmo Pharmaceuticals NV's highest Pretax Margin was 419.57%. The lowest was -48.23%. And the median was 30.43%.

Cosmo Pharmaceuticals NV Pre-Tax Income Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV Pre-Tax Income Chart

Cosmo Pharmaceuticals NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Pre-Tax Income

Get a 7-Day Free Trial

-19.70

-23.26

-7.49

24.98

24.15

Cosmo Pharmaceuticals NV Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Pre-Tax Income	Get a 7-Day Free Trial															-5.10	29.84	9.32	15.18	3.58

Competitive Comparison of Cosmo Pharmaceuticals NV's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmo Pharmaceuticals NV's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cosmo Pharmaceuticals NV's Pre-Tax Income falls into.

Cosmo Pharmaceuticals NV Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cosmo Pharmaceuticals NV's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	27.688	+	0	+	-9.039	+	2.902	+	2.601
	=	24.2

Cosmo Pharmaceuticals NV's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	6.949	+	0	+	-4.424	+	1.538	+	-0.48
	=	3.6

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF18.8 Mil.

Cosmo Pharmaceuticals NV (CHIX:COPNz) Pre-Tax Income Explanation

Cosmo Pharmaceuticals NV's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	3.583	/	42.592
	=	8.41%

During the past 13 years, Cosmo Pharmaceuticals NV's highest Pretax Margin was 419.57%. The lowest was -48.23%. And the median was 30.43%.

Cosmo Pharmaceuticals NV Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (CHIX:COPNz) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

CMOPF:USA C43:Germany COPN:Switzerland

Address

Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2

Website

https://www.cosmopharma.com

Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Headlines

No Headlines